Lead Product(s): GDA-201
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: Phase I Product Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 02, 2020
The data showcased the results of updated results from a Phase 1 clinical study of GDA-201 in patients with non-Hodgkin lymphoma and multiple myeloma.